Ambroxol

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

Ambroxol as a Treatment for Parkinson's Disease Dementia

Ambroxol in Disease Modification in Parkinson Disease

Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy

Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

GREAT; GRoningen Early-PD Ambroxol Treatment Trial

A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric and functional outcomes of Ambroxol in New and Early patients with prodromal and mild Dementia with Lewybodies (The ANeED study)

Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series

High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)